---
title: Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children
nct_id: NCT02545764
overall_status: COMPLETED
phase: NA
sponsor: St. Pölten University of Applied Sciences
study_type: INTERVENTIONAL
primary_condition: Pediatric Obesity
countries: Austria
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02545764.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02545764"
ct_last_update_post_date: 2018-07-17
last_seen_at: "2026-05-12T07:23:13.585Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Training Induced Reduction of Lower-limb Joint Loads During Locomotion in Obese Children

**Official Title:** The Effects of a Strength and Neuromuscular Exercise Programme for the Lower Extremity on Knee Load, Pain and Function in Obese Children and Adolescents: a Randomised, Single-blinded Controlled Trial

**NCT ID:** [NCT02545764](https://clinicaltrials.gov/study/NCT02545764)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 48
- **Lead Sponsor:** St. Pölten University of Applied Sciences
- **Collaborators:** University of Vienna, Medical University of Vienna, Danube University Krems
- **Conditions:** Pediatric Obesity, Lower Extremity Biomechanics
- **Start Date:** 2015-09
- **CT.gov Last Update:** 2018-07-17

## Brief Summary

Childhood obesity is one of the most critical and accelerating health challenges throughout the world. It is a major risk factor for developing varus/valgus misalignments of the knee joint. The combination of misalignment at the knee and excess body mass may result in increased joint stress and damage to articular cartilage. A training programme, which aims at developing a more neutral alignment of the trunk and lower limbs during movement tasks may be able to reduce knee loading during locomotion. Despite the large number of guidelines for muscle strength training and neuromuscular exercises that exists, most are not specifically designed to target the obese children and adolescent demographic.

The purpose of this study is to evaluate a training programme which combines strength and neuromuscular exercises specifically designed to the needs and limitations of obese children and adolescents and analyse the effects of the training programme from a biomechanical and clinical point of view.

## Eligibility

- **Minimum age:** 10 Years
- **Maximum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Male or female
* Age: 10 -18 years
* BMI greater than the 97th percentile
* Availability: can participate in two exercises session per week for a period of 12 weeks

Exclusion Criteria:

* Present syndromes
* Chronic joint diseases, osteoarthritic surgery or
* Neuro-motor diseases
```

## Arms

- **Intervention** (EXPERIMENTAL) — Strength and neuromuscular exercise programme
- **Control** (NO_INTERVENTION) — Control group will receive opportunity for the training programme after data capturing is finished

## Interventions

- **Strength and neuromuscular exercise programme** (OTHER) — 12 weeks strength and neuromuscular exercise programme for the lower extremity

## Primary Outcomes

- **Overall peak external frontal knee moment and impulse** _(time frame: Baseline and 12 weeks)_ — Assessed by 3D gait analysis during walking

## Secondary Outcomes

- **Physical examination** _(time frame: Baseline and 12 weeks)_
- **Knee Injury and Osteoarthritis Outcome Score (KOOS)** _(time frame: Baseline and 12 weeks)_
- **Gait pattern** _(time frame: Baseline and 12 weeks)_
- **Adherence to the training programme** _(time frame: Participants will be followed for the duration of the intervention (12 weeks))_
- **Ratings of knee related pain** _(time frame: Participants will be followed for the duration of the intervention (12 weeks))_

## Locations (1)

- Department of Paediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `sponsor.collaborators` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.department of paediatrics and adolescent medicine, medical university of vienna|vienna||austria` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02545764.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02545764*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*